1. Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer
   You-Wei Zhang et al, 2014, Epigenetics CrossRef
2. Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma
   Lien Provez et al, 2023, Cancers CrossRef
3. Identification of miRNAs and differentially expressed genes in early phase non-small cell lung cancer
   WEN TIAN et al, 2016, Oncology Reports CrossRef
4. Wnt Signaling Pathway in Non-Small Cell Lung Cancer
   D. J. Stewart, 2014, JNCI Journal of the National Cancer Institute CrossRef
5. The role of Evi/Wntless in exporting Wnt proteins
   Lucie Wolf et al, 2023, Development CrossRef
6. Prognostic Potential and Tumor Growth-Inhibiting Effect of Plasma Advanced Glycation End Products in Non-Small Cell Lung Carcinoma
   Babett Bartling et al, 2011, Molecular Medicine CrossRef
7. Wnt signaling as potential therapeutic target in lung cancer
   Jiali Yang et al, 2016, Expert Opinion on Therapeutic Targets CrossRef
8. Application of porcupine inhibitors in stem cell fate determination
   Ashkan Kalantary‐Charvadeh et al, 2020, Chemical Biology & Drug Design CrossRef
9. Porcn as a novel therapeutic target in cancer therapy: A review
   Mortaza Raeisi et al, 2022, Cell Biology International CrossRef
10. PORCN Moonlights in a Wnt-Independent Pathway That Regulates Cancer Cell Proliferation
    Tracy M. Covey et al, 2012, PLoS ONE CrossRef
11. The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases
    Zeeshan Sattar et al, 2021, Pulmonary Medicine CrossRef